(0.28%) 5 145.75 points
(0.16%) 38 501 points
(0.43%) 17 923 points
(-0.75%) $83.22
(1.20%) $1.946
(-0.20%) $2 342.40
(-0.15%) $27.50
(2.72%) $947.15
(-0.06%) $0.934
(-0.07%) $11.02
(-0.29%) $0.798
(1.34%) $93.10
@ $0.773
发出时间: 15 Feb 2024 @ 04:29
回报率: -39.95%
上一信号: Feb 14 - 23:21
上一信号:
回报率: 3.62 %
Live Chart Being Loaded With Signals
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics...
Stats | |
---|---|
今日成交量 | 2.62M |
平均成交量 | 7.57M |
市值 | 224.12M |
EPS | $0 ( 2024-02-07 ) |
下一个收益日期 | ( $-0.150 ) 2024-05-26 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.420 |
ATR14 | $0.00200 (0.43%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-18 | Hibbs Kathy L | Buy | 38 548 | Class A Common Stock |
2024-04-18 | Hibbs Kathy L | Sell | 38 548 | Class A Common Stock |
2024-04-18 | Hibbs Kathy L | Sell | 38 548 | Stock Option (Right to Buy) |
2024-04-04 | Hibbs Kathy L | Buy | 38 548 | Class A Common Stock |
2024-04-04 | Hibbs Kathy L | Sell | 38 548 | Class A Common Stock |
INSIDER POWER |
---|
73.77 |
Last 100 transactions |
Buy: 15 283 999 | Sell: 2 077 892 |
音量 相关性
23andMe Holding Co. 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
23andMe Holding Co. 相关性 - 货币/商品
23andMe Holding Co. 财务报表
Annual | 2022 |
营收: | $299.49M |
毛利润: | $134.50M (44.91 %) |
EPS: | $-0.690 |
FY | 2022 |
营收: | $299.49M |
毛利润: | $134.50M (44.91 %) |
EPS: | $-0.690 |
FY | 2022 |
营收: | $271.89M |
毛利润: | $132.95M (48.90 %) |
EPS: | $-0.600 |
FY | 2021 |
营收: | $243.92M |
毛利润: | $117.01M (47.97 %) |
EPS: | $-0.398 |
Financial Reports:
No articles found.
23andMe Holding Co.
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No.3) Limited to leverage genetic insights to validate, develop, and commercialize drugs. The company was founded in 2006 and is headquartered in South San Francisco, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。